IMPACT OF COLOSTRUM-BASED NEUTRACEUTICALS ON FUNCT.. (GI-Neu)
IMPACT OF COLOSTRUM-BASED NEUTRACEUTICALS ON FUNCTIONAL GASTROINTESTINAL DISORDERS
Start date: Oct 1, 2013,
End date: Sep 30, 2017
The aim of this proposal is to create a multiannual joint programme of collaboration between research-intensive non-commercial (academic) and commercial (industry) organisations to increase knowledge on the effects of colostrum-based neutraceuticals on functional gastrointestinal disorders (FGID). Functional gastrointestinal disorders such as irritable bowel syndrome represent well-known issues, yet the vast majority of attempts to address them to date have been led by either the public or the private sector alone. The current proposal is designed to exploit the complimentary expertise of non-commercial and commercial organisations through knowledge sharing and transfer between sectors. This will be achieved by establishing a Network of Excellence (NoE) that will incorporate staff secondments and the recruitment of researchers from outside the partnership for the purpose of networking, training activities, workshops, and joint research. Thus, this proposal will foster mutual understanding of the different cultural settings and skill requirements of the non-commercial and commercial sectors, encouraging entrepreneurship and long-term intersectoral collaboration regarding the effects of colostrum-based neutraceuticals on functional gastrointestinal disorders. Eventually, this partnership may help translate creative ideas into innovative products and processes that can efficiently address existing challenges on gastrointestinal issues.
Get Access to the 1st Network for European Cooperation